296 related articles for article (PubMed ID: 21571797)
1. Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment.
Maecke HR; Reubi JC
J Nucl Med; 2011 Jun; 52(6):841-4. PubMed ID: 21571797
[TBL] [Abstract][Full Text] [Related]
2. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.
Schottelius M; Poethko T; Herz M; Reubi JC; Kessler H; Schwaiger M; Wester HJ
Clin Cancer Res; 2004 Jun; 10(11):3593-606. PubMed ID: 15173065
[TBL] [Abstract][Full Text] [Related]
3. Receptor radionuclide therapy of tumors: a road from basic research to clinical applications.
Bodei L; Paganelli G; Mariani G
J Nucl Med; 2006 Mar; 47(3):375-7. PubMed ID: 16513604
[No Abstract] [Full Text] [Related]
4. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.
Eberle AN; Mild G
J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167
[TBL] [Abstract][Full Text] [Related]
5. Preclinical and clinical studies of peptide receptor radionuclide therapy.
Pool SE; Krenning EP; Koning GA; van Eijck CH; Teunissen JJ; Kam B; Valkema R; Kwekkeboom DJ; de Jong M
Semin Nucl Med; 2010 May; 40(3):209-18. PubMed ID: 20350630
[TBL] [Abstract][Full Text] [Related]
6. Peptides and receptors in image-guided therapy: theranostics for neuroendocrine neoplasms.
Baum RP; Kulkarni HR; Carreras C
Semin Nucl Med; 2012 May; 42(3):190-207. PubMed ID: 22475428
[TBL] [Abstract][Full Text] [Related]
7. Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer.
Wang M; Caruano AL; Lewis MR; Meyer LA; VanderWaal RP; Anderson CJ
Cancer Res; 2003 Oct; 63(20):6864-9. PubMed ID: 14583484
[TBL] [Abstract][Full Text] [Related]
8. Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size.
de Jong M; Breeman WA; Bernard BF; Bakker WH; Visser TJ; Kooij PP; van Gameren A; Krenning EP
J Nucl Med; 2001 Dec; 42(12):1841-6. PubMed ID: 11752083
[TBL] [Abstract][Full Text] [Related]
9. Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumors.
Frilling A; Weber F; Saner F; Bockisch A; Hofmann M; Mueller-Brand J; Broelsch CE
Surgery; 2006 Dec; 140(6):968-76; discussion 976-7. PubMed ID: 17188146
[TBL] [Abstract][Full Text] [Related]
10. Radiopeptide imaging and therapy in Europe.
Ambrosini V; Fani M; Fanti S; Forrer F; Maecke HR
J Nucl Med; 2011 Dec; 52 Suppl 2():42S-55S. PubMed ID: 22144555
[TBL] [Abstract][Full Text] [Related]
11. Radiopeptides for Imaging and Therapy: A Radiant Future.
Chatalic KL; Kwekkeboom DJ; de Jong M
J Nucl Med; 2015 Dec; 56(12):1809-12. PubMed ID: 26514175
[TBL] [Abstract][Full Text] [Related]
12. Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide.
Clifford T; Boswell CA; Biddlecombe GB; Lewis JS; Brechbiel MW
J Med Chem; 2006 Jul; 49(14):4297-304. PubMed ID: 16821789
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor imaging: current status and future perspectives.
Bohuslavizki KH
J Nucl Med; 2001 Jul; 42(7):1057-8. PubMed ID: 11438628
[No Abstract] [Full Text] [Related]
14. Veterinary nuclear medicine.
Krzemiński M; Lass P; Teodorczyk J; Krajka J
Nucl Med Rev Cent East Eur; 2004; 7(2):177-82. PubMed ID: 15968607
[No Abstract] [Full Text] [Related]
15. (68)Ga-labeled peptides in tumor imaging.
Maecke HR; Hofmann M; Haberkorn U
J Nucl Med; 2005 Jan; 46 Suppl 1():172S-8S. PubMed ID: 15653666
[TBL] [Abstract][Full Text] [Related]
16. [Applications of somatostatin receptor scintigraphy in oncology: the need to incorporate SPECT into the imaging protocol].
Valdés Olmos RA
Rev Esp Med Nucl; 2003; 22(2):65-7. PubMed ID: 12646093
[No Abstract] [Full Text] [Related]
17. Radiolabeling of DOTATOC with the long-lived positron emitter 44Sc.
Pruszyński M; Majkowska-Pilip A; Loktionova NS; Eppard E; Roesch F
Appl Radiat Isot; 2012 Jun; 70(6):974-9. PubMed ID: 22464928
[TBL] [Abstract][Full Text] [Related]
18. Tumour targeting with radiometals for diagnosis and therapy.
Ramogida CF; Orvig C
Chem Commun (Camb); 2013 May; 49(42):4720-39. PubMed ID: 23599005
[TBL] [Abstract][Full Text] [Related]
19. Experiences with high dose radiopeptide therapy: the health physics perspective.
Espenan GD; Nelson JA; Fisher DR; Diaco DS; McCarthy KE; Anthony LB; Maloney TJ; Woltering EA
Health Phys; 1999 Mar; 76(3):225-35. PubMed ID: 10025645
[TBL] [Abstract][Full Text] [Related]
20. Radiometal-labeled somatostatin analogs for applications in cancer imaging and therapy.
Lewis JS; Anderson CJ
Methods Mol Biol; 2007; 386():227-40. PubMed ID: 18604948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
